Skip to main content

NATIXIS ADVISORS, LLC

Position in ABBV — AbbVie Inc.

CIK 1018331 Boston, MA

Position in ABBV

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$285,600,908
-$12,553,407 QoQ
Shares Held
1,313,168
+0.6% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $2,890,133,285 across 14 Drug Manufacturers - General names. ABBV ranks #5 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ABBV
AbbVie Inc.
This page
1,313,168 $285,600,908

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $285,600,908 1,313,168
2025-12-31 $298,154,315 1,304,890
2025-09-30 $300,350,213 1,297,185
2025-06-30 $241,631,576 1,301,754
2025-03-31 $269,729,342 1,287,368
2024-12-31 $212,857,944 1,197,850
2024-09-30 $239,624,403 1,213,411
2024-06-30 $197,806,125 1,153,254
2024-03-31 $198,199,459 1,088,410
2023-12-31 $154,415,981 996,425
2023-09-30 $134,884,393 904,900
2023-06-30 $85,097,892 631,618
2023-03-31 $117,423,337 736,797
2022-12-31 $109,680,181 678,672
2022-09-30 $89,190,597 664,560
2022-06-30 $88,258,143 576,248
2022-03-31 $97,544,828 601,720
2021-12-31 $71,375,973 527,149
2021-09-30 $50,165,266 465,053
2021-06-30 $53,136,793 471,740
2021-03-31 $45,899,456 424,131
2020-12-31 $40,908,690 381,789
2020-09-30 $39,793,625 454,317
2020-06-30 $60,695,660 618,208
2020-03-31 $42,912,340 563,228